These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8983878)

  • 1. Plasma arachidonic acid-rich phospholipids in Crohn's disease: response to treatment.
    Pereira SP; Cassell TB; Engelman JL; Sladen GE; Murphy GM; Dowling RH
    Clin Sci (Lond); 1996 Oct; 91(4):509-12. PubMed ID: 8983878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished phospholipid incorporation of essential fatty acids in peripheral blood leucocytes from patients with Crohn's disease: correlation with zinc depletion.
    Cunnane SC; Ainley CC; Keeling PW; Thompson RP; Crawford MA
    J Am Coll Nutr; 1986; 5(5):451-8. PubMed ID: 3097102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long-chain fatty acid composition in patients with Crohn's disease.
    Belluzzi A; Brignola C; Campieri M; Gionchetti P; Rizzello F; Boschi S; Cunanne S; Miglioli M; Barbara L
    Aliment Pharmacol Ther; 1994 Feb; 8(1):127-30. PubMed ID: 8186338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease.
    Zoli G; Carè M; Parazza M; Spanò C; Biagi PL; Bernardi M; Gasbarrini G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):735-40. PubMed ID: 9305483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma viscosity in inflammatory bowel disease.
    Lobo AJ; Jones SC; Juby LD; Axon AT
    J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of budesonide with prednisolone for active Crohn's disease.
    Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
    N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential fatty acid status in paediatric Crohn's disease: relationship with disease activity and nutritional status.
    Trebble TM; Wootton SA; May A; Erlewyn-Lajeunesse MD; Chakraborty A; Mullee MA; Stroud MA; Beattie RM
    Aliment Pharmacol Ther; 2003 Aug; 18(4):433-42. PubMed ID: 12940929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
    Kjeldsen J; Schaffalitzky de Muckadell OB; Junker P
    Gut; 1995 Dec; 37(6):805-10. PubMed ID: 8537052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.
    Esteve-Comas M; Ramírez M; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Moreno J; Humbert P; Guilera M
    Gut; 1992 Oct; 33(10):1365-9. PubMed ID: 1446861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease.
    Lomer MC; Grainger SL; Ede R; Catterall AP; Greenfield SM; Cowan RE; Vicary FR; Jenkins AP; Fidler H; Harvey RS; Ellis R; McNair A; Ainley CC; Thompson RP; Powell JJ
    Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):377-84. PubMed ID: 15716665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled double blind study of azathioprine in the management of Crohn's disease.
    Candy S; Wright J; Gerber M; Adams G; Gerig M; Goodman R
    Gut; 1995 Nov; 37(5):674-8. PubMed ID: 8549944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).
    Lorenz-Meyer H; Bauer P; Nicolay C; Schulz B; Purrmann J; Fleig WE; Scheurlen C; Koop I; Pudel V; Carr L
    Scand J Gastroenterol; 1996 Aug; 31(8):778-85. PubMed ID: 8858747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children.
    Ruuska T; Savilahti E; Mäki M; Ormälä T; Visakorpi JK
    J Pediatr Gastroenterol Nutr; 1994 Aug; 19(2):175-80. PubMed ID: 7815239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral butyrate for mildly to moderately active Crohn's disease.
    Di Sabatino A; Morera R; Ciccocioppo R; Cazzola P; Gotti S; Tinozzi FP; Tinozzi S; Corazza GR
    Aliment Pharmacol Ther; 2005 Nov; 22(9):789-94. PubMed ID: 16225487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease.
    Beattie RM; Camacho-Hübner C; Wacharasindhu S; Cotterill AM; Walker-Smith JA; Savage MO
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):483-9. PubMed ID: 9876346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn's disease.
    Sun CM; Wu J; Zhang H; Shi G; Chen ZT
    World J Gastroenterol; 2017 Nov; 23(44):7888-7898. PubMed ID: 29209130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas.
    Sakurai T; Matsui T; Yao T; Takagi Y; Hirai F; Aoyagi K; Okada M
    JPEN J Parenter Enteral Nutr; 2002; 26(2):98-103. PubMed ID: 11871742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
    Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
    Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Crohn's disease is associated with low vitamin D levels.
    Jørgensen SP; Hvas CL; Agnholt J; Christensen LA; Heickendorff L; Dahlerup JF
    J Crohns Colitis; 2013 Nov; 7(10):e407-13. PubMed ID: 23403039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.